Blastocystis: Diagnostechs™ Clinical & Research Laboratory a Question of Pathogenicity Quarterly Newsletter Carrie C
Total Page:16
File Type:pdf, Size:1020Kb
ChronoBiology LETTER Spring 2014 — 17th Edition Blastocystis: DiagnosTechs™ Clinical & Research Laboratory A Question of Pathogenicity Quarterly Newsletter Carrie C. McMillin, ND Articles in this edition 1 Blastocystis: A Question of Pathogenicity With our growing knowledge of the existence of various genotypes may be 3 Diagnos-Techs Introduces— intricacies of the gut microbiome, we the reason for conflicting data,1-3 as it Matthew Stoner, PhD are often faced with difficult questions is possible that only some isotypes are Scott Buesing, ND regarding the clinical implications of pathogenic.4 In addition, it is difficult 4 The Therapy Corner: The Anxiety- Depression Spectrum this knowledge. Recent improvements to differentiate among Blastocystis in diagnostic methods allow us to more isotypes based on morphology. As a accurately identify which microbes result, some studies have employed are present; however, as clinicians the use of polymerase chain reaction we need to make the decision to (PCR) testing to distinguish between treat or not to treat—a decision various genotypes. In one of the most that is not always extensive studies straightforward. conducted, it was Many organisms are found that among Join Diagnos-Techs in not clearly classified these genotypes, Chicago for Digestive as pathogenic or Blastocystis can be nonpathogenic, grouped into seven Disease Week! resulting in distinct subtypes,5,6 confusion around although some May 4-6 their clinical sources propose McCormick Place significance. more. It has also One such group been shown that Chicago, IL of organisms transmission can that has been occur between Booth #3516 widely disputed Blastocystis cysts. www.cdc.gov/dpdx animals and is Blastocystis humans, illustrating Register at www.ddw.org spp. There has been considerable that animals can serve as a large discussion regarding its status as a potential reservoir for human true pathogen and the legitimacy of infections.1 a disease (blastocystosis) caused by Need assistance with this organism. A review of current Historically, there has also been much test interpretation? literature, however, shows that debate regarding the taxonomic accumulating evidence strongly classification of Blastocystis. Since We’re here to help! suggests that Blastocystis is a its discovery, it has been classified potentially pathogenic organism. as the cyst of a flagellate, vegetable, Call to set up an appointment yeast, and fungus, only recently with a member of our There are several confounding having been reclassified as a protist. medical support team. factors that make it difficult to clearly Today Blastocystis is included as a categorize Blastocystis. First of all, stramenopile, a class of botanical 1-800-878-3787 humans are host to many different protists such as brown algae that genotypes of Blastocystis. The possess flagella with mastigonemes Continued on page 2. ChronoBiology LETTER Blastocystis Interestingly, several surveys fecal leukocytes,28 and cutaneous continued from front cover. have reported that Blastocystis rashes (with urticaria being most (hair-like structures projecting was more frequently isolated in notable).29 In general, Blastocystis is from the flagellum). Blastocystis, immunocompetent individuals non-invasive,30 with extraintestinal however, is nonmotile and does suffering from intestinal disorders infections being a rare occurrence not possess flagella. A new class for than similar patients without GI and only then when mediated 19-23 Blastocystis was therefore created— symptoms. Another survey by another pathogen. It has also Blastocystea.1,7 pointed out an increased prevalence been noted that mixed infections of Blastocystis isolation in atopic with Blastocystis and Entamoeba As mentioned earlier, the various patients.24 histolytica are not uncommon.31 Blastocystis subtypes can be There is accumulating evidence of transmitted between animals and More recent research has focused an association between Blastocystis humans in addition to human-human on investigating whether the biology and irritable bowel syndrome (IBS). transmission. This makes it difficult to and pathogenicity of Blastocystis is Specifically, some studies have assign Blastocystis species according related to genotype. Unfortunately, shown an increased prevalence to the host of origin. In fact, this no conclusive data has been found. of Blastocystis in patients with IBS may be one reason for conflicting It has, however, been suggested that compared to IBS-negative patients reports regarding cell variations subtype 1 is associated with disease, with GI symptoms.32,33 It is not yet and pathogenesis in the past. It while subtypes 2 and 3 appear to clear whether Blastocystis can be 1 has been noted in epidemiological be nonpathogenic, although more considered an etiological agent of IBS studies that subtype 3 is the most research is needed. or IBS simply creates an environment frequently isolated. As such, it is in which Blastocystis can thrive.34 widely believed that this is the most likely genotype of human origin, There is As with many other organisms, formerly designated as B. hominis.8-11 accumulating clinical outcomes of the presence of Because humans can be infected Blastocystis vary considerably based by numerous Blastocystis subtypes, evidence of an on numerous factors, making it is and the various subtypes are difficult to predict its pathogenic indistinguishable from each other via association between potential. Some studies have shown microscopy, it is now recommended Blastocystis and that treatment with metronidazole,35 that laboratories report the presence nitazoxanide,36 and trimethoprim- of Blastocystis spp. instead of irritable bowel sulfamethoxazole (TMP-SMX)37 Blastocystis hominis. (Note: This is a has resulted in eradication of the syndrome (IBS). change that you will soon see in the organism and resolution of GI Diagnos-Techs microscopy reports.) symptoms. However, these drugs Blastocystis-associated illness is are all broad-spectrum antibiotics; Although it can be found most commonly associated with therefore, it is difficult to ascertain worldwide,12,13 Blastocystis has a abdominal pain and acute or chronic if clinical cure was instead the result higher prevalence rate in developing diarrhea, although it has also of treatment and eradication of a countries. This has been linked been linked to nausea, vomiting, separate and unidentified pathogenic 1,25 to poor hygiene, contaminated bloating, flatulence, and anorexia. organism. food and water consumption, and Diagnosis is made by microscopic exposure to animals.14 Recent stool examination (O&P testing), Some herbs that have been found studies point to the classification ideally conducted on fecal samples to reduce or inhibit growth of 26 of Blastocystis as pathogenic or from three separate days. There Blastocystis spp. include Coptis opportunistic, concluding that it is some evidence that the acute GI chinensis, Brucea javanica, may be associated with a variety of presentations are associated with Punica granatum, Picrorhiza disorders. It has also been suggested an increased infection density, most scrophulariiflora, and Allium that immunocompromised patients commonly greater than five parasites sativum.38-42 In one study, children 1,16,19 are at greater risk for Blastocystis- per high power field. Other signs treated with Saccharomyces 27 associated disorders.1,15-18 and symptoms include eosinophilia, cerevisiae had a higher cure rate than 2 © 2014 Diagnos-Techs, Inc. All rights reserved. Spring 2014 — 17th Edition Diagnos-Techs Introduces— those receiving metronidazole.43 It has also been suggested that a high fiber, low lactose diet may be an important component to a Matthew Stoner, PhD Director of Research and Blastocystis treatment plan. Excellence. Additionally, while at the Development Despite considerable gaps in our University of Rhode Island, he lectured understanding of this organism, Dr. Stoner in the areas of endocrinology and it is worth noting that there are completed his PhD laboratory techniques in molecular no studies to date that prove in Toxicology at biology and trained and mentored unequivocally that Blastocystis Texas A&M junior scientists. Most recently, Dr. is nonpathogenic, and there is University, where he Stoner was Senior Research Scientist at accumulating evidence around its studied estrogen CertiChem, Inc., where he optimized pathogenic potential. Treatment receptor-modulated sensitive bioassays for the detection of should be considered for both gene expression in breast cancer and endocrine-active chemicals that leach acute and chronic cases in the presence of associated symptoms, endometrial cancer. He subsequently from consumer products. He has more appropriate clinical context, and completed postdoctoral training in than 20 peer-reviewed publications in the absence of other causative Molecular Toxicology at the Pennsylvania journals that cover diverse areas of cell pathologies. State University. Dr. Stoner then was and molecular biology and toxicology. appointed Research Assistant Professor As the Director of Research and For references, please see Newsletter section of website (www.diagnostechs. in the College of Pharmacy at the Development at Diagnos-Techs, Dr. com). University of Rhode Island, where he Stoner investigates and incorporates established a research laboratory into production new technologies and supported by the Rhode Island IDeA methodologies to expand our clinical Network of Biomedical Research diagnostic test offerings.